The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
The global Thrombin market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 704.7 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Thrombin include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Thrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin.
Report Scope
The Thrombin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Segment by Type
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Segment by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thrombin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.
The global Thrombin market was valued at US$ 565 million in 2023 and is anticipated to reach US$ 704.7 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.
North American market for Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Thrombin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Thrombin include Takeda, Bayer, CSL, Grifols, GE Healthcare, Hualan Biological, Haematologic Technologies Inc., Pfizer and Octapharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Thrombin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thrombin.
Report Scope
The Thrombin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Thrombin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Thrombin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
Bayer
CSL
Grifols
GE Healthcare
Hualan Biological
Haematologic Technologies Inc.
Pfizer
Octapharma
Omrix Biopharmaceuticals Ltd.
Shanghai RAAS
Segment by Type
Powder Form
Solution Form
Pad Form
Spray Kits
Others
Segment by Application
Hospitals
Diagnostics & Clinics
Academic and Research Institute
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Thrombin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Thrombin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Thrombin Market Overview
1.1 Product Overview and Scope of Thrombin
1.2 Thrombin Segment by Type
1.2.1 Global Thrombin Market Value Comparison by Type (2024-2030)
1.2.2 Powder Form
1.2.3 Solution Form
1.2.4 Pad Form
1.2.5 Spray Kits
1.2.6 Others
1.3 Thrombin Segment by Application
1.3.1 Global Thrombin Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Diagnostics & Clinics
1.3.4 Academic and Research Institute
1.4 Global Thrombin Market Size Estimates and Forecasts
1.4.1 Global Thrombin Revenue 2019-2030
1.4.2 Global Thrombin Sales 2019-2030
1.4.3 Global Thrombin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Thrombin Market Competition by Manufacturers
2.1 Global Thrombin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Thrombin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Thrombin Average Price by Manufacturers (2019-2024)
2.4 Global Thrombin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Thrombin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Thrombin, Product Type & Application
2.7 Thrombin Market Competitive Situation and Trends
2.7.1 Thrombin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Thrombin Players Market Share by Revenue
2.7.3 Global Thrombin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Thrombin Retrospective Market Scenario by Region
3.1 Global Thrombin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Thrombin Global Thrombin Sales by Region: 2019-2030
3.2.1 Global Thrombin Sales by Region: 2019-2024
3.2.2 Global Thrombin Sales by Region: 2025-2030
3.3 Global Thrombin Global Thrombin Revenue by Region: 2019-2030
3.3.1 Global Thrombin Revenue by Region: 2019-2024
3.3.2 Global Thrombin Revenue by Region: 2025-2030
3.4 North America Thrombin Market Facts & Figures by Country
3.4.1 North America Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Thrombin Sales by Country (2019-2030)
3.4.3 North America Thrombin Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Thrombin Market Facts & Figures by Country
3.5.1 Europe Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Thrombin Sales by Country (2019-2030)
3.5.3 Europe Thrombin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Thrombin Market Facts & Figures by Country
3.6.1 Asia Pacific Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Thrombin Sales by Country (2019-2030)
3.6.3 Asia Pacific Thrombin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Thrombin Market Facts & Figures by Country
3.7.1 Latin America Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Thrombin Sales by Country (2019-2030)
3.7.3 Latin America Thrombin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Thrombin Market Facts & Figures by Country
3.8.1 Middle East and Africa Thrombin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Thrombin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Thrombin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Thrombin Sales by Type (2019-2030)
4.1.1 Global Thrombin Sales by Type (2019-2024)
4.1.2 Global Thrombin Sales by Type (2025-2030)
4.1.3 Global Thrombin Sales Market Share by Type (2019-2030)
4.2 Global Thrombin Revenue by Type (2019-2030)
4.2.1 Global Thrombin Revenue by Type (2019-2024)
4.2.2 Global Thrombin Revenue by Type (2025-2030)
4.2.3 Global Thrombin Revenue Market Share by Type (2019-2030)
4.3 Global Thrombin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Thrombin Sales by Application (2019-2030)
5.1.1 Global Thrombin Sales by Application (2019-2024)
5.1.2 Global Thrombin Sales by Application (2025-2030)
5.1.3 Global Thrombin Sales Market Share by Application (2019-2030)
5.2 Global Thrombin Revenue by Application (2019-2030)
5.2.1 Global Thrombin Revenue by Application (2019-2024)
5.2.2 Global Thrombin Revenue by Application (2025-2030)
5.2.3 Global Thrombin Revenue Market Share by Application (2019-2030)
5.3 Global Thrombin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Thrombin Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Thrombin Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 CSL
6.3.1 CSL Corporation Information
6.3.2 CSL Description and Business Overview
6.3.3 CSL Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSL Thrombin Product Portfolio
6.3.5 CSL Recent Developments/Updates
6.4 Grifols
6.4.1 Grifols Corporation Information
6.4.2 Grifols Description and Business Overview
6.4.3 Grifols Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Grifols Thrombin Product Portfolio
6.4.5 Grifols Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GE Healthcare Thrombin Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Hualan Biological
6.6.1 Hualan Biological Corporation Information
6.6.2 Hualan Biological Description and Business Overview
6.6.3 Hualan Biological Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Biological Thrombin Product Portfolio
6.6.5 Hualan Biological Recent Developments/Updates
6.7 Haematologic Technologies Inc.
6.6.1 Haematologic Technologies Inc. Corporation Information
6.6.2 Haematologic Technologies Inc. Description and Business Overview
6.6.3 Haematologic Technologies Inc. Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Haematologic Technologies Inc. Thrombin Product Portfolio
6.7.5 Haematologic Technologies Inc. Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Corporation Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pfizer Thrombin Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Octapharma
6.9.1 Octapharma Corporation Information
6.9.2 Octapharma Description and Business Overview
6.9.3 Octapharma Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Octapharma Thrombin Product Portfolio
6.9.5 Octapharma Recent Developments/Updates
6.10 Omrix Biopharmaceuticals Ltd.
6.10.1 Omrix Biopharmaceuticals Ltd. Corporation Information
6.10.2 Omrix Biopharmaceuticals Ltd. Description and Business Overview
6.10.3 Omrix Biopharmaceuticals Ltd. Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Omrix Biopharmaceuticals Ltd. Thrombin Product Portfolio
6.10.5 Omrix Biopharmaceuticals Ltd. Recent Developments/Updates
6.11 Shanghai RAAS
6.11.1 Shanghai RAAS Corporation Information
6.11.2 Shanghai RAAS Thrombin Description and Business Overview
6.11.3 Shanghai RAAS Thrombin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shanghai RAAS Thrombin Product Portfolio
6.11.5 Shanghai RAAS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Thrombin Industry Chain Analysis
7.2 Thrombin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Thrombin Production Mode & Process
7.4 Thrombin Sales and Marketing
7.4.1 Thrombin Sales Channels
7.4.2 Thrombin Distributors
7.5 Thrombin Customers
8 Thrombin Market Dynamics
8.1 Thrombin Industry Trends
8.2 Thrombin Market Drivers
8.3 Thrombin Market Challenges
8.4 Thrombin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
